CMVRX | VMVAX | CMVRX / VMVAX | |
Total Expense Ratio | 1.38 | 0.07 | 1,971% |
Annual Report Gross Expense Ratio | 1.38 | 0.07 | 1,971% |
Fund Existence | 20 years | 14 years | - |
Gain YTD | 4.581 | 5.198 | 88% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.48B | 31B | 8% |
Annual Yield % from dividends | 0.45 | 2.22 | 20% |
Returns for 1 year | 1.48 | 7.67 | 19% |
Returns for 3 years | 12.86 | 17.51 | 73% |
Returns for 5 years | 51.26 | 65.15 | 79% |
Returns for 10 years | -11.52 | 87.87 | -13% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AAEMX | 12.24 | 0.05 | +0.41% |
Alger Emerging Markets A | |||
MACPX | 27.32 | 0.03 | +0.11% |
BlackRock Balanced Institutional | |||
ANTUX | 10.62 | 0.01 | +0.09% |
American Century Non-US IntrsVal Inv | |||
BTEKX | 79.10 | -0.04 | -0.05% |
BlackRock Technology Opportunities K | |||
HOORX | 28.85 | -0.11 | -0.38% |
Hartford Schroders US Small Cap Opps R3 |